| Anti-cancer effects of cyclic peptide alos4 in a human melanoma mouse model B Levi, S Yacobovich, M Kirby, M Becker, O Agranyoni, B Redko, ... International Journal of Molecular Sciences 22 (17), 9579, 2021 | 5 | 2021 |
| Metabolic alterations and cellular responses to β-Hydroxybutyrate treatment in breast cancer cells H Fulman-Levy, R Cohen-Harazi, B Levi, L Argaev-Frenkel, I Abramovich, ... Cancer & Metabolism 12 (1), 16, 2024 | 3 | 2024 |
| Identification and molecular characterization of cancer cells survived under glucose starvation E Nesher, B Levi, H Levy, R Cohen-Harazi, I Koman Cancer Research 83 (7_Supplement), 6044-6044, 2023 | | 2023 |
| Targeted Modulation of Interferon Response-Related Genes with IFN-Alpha/Lambda Inhibition D Sur, K Leonova, B Levi, SI Markowitz, R Cohen-Harazi, I Gitlin, ... International Journal of Molecular Sciences 23 (13), 7248, 2022 | | 2022 |
| Anticancer effect of a new cyclic peptide ALOS4 is associated with its systemic anti-inflammatory activity E Nesher, A Pinhasov, M Becker, M Kirby, RC Harazi, S Yakobovich, ... Cancer Research 78 (13_Supplement), 2866-2866, 2018 | | 2018 |
